FORM

$94.71

Post-MarketAs of Mar 17, 8:00 PM UTC

FormFactor, Inc.

Recent News

Simply Wall St.
Mar 17, 2026

Why The FormFactor (FORM) Story Is Shifting As Analysts Rework Valuation Targets

FormFactor’s fair value price target sits at US$84.11, unchanged in the latest update, even as the underlying model inputs are refined. That stability comes alongside a wave of fresh analyst targets, with some firms lifting their numbers by more than US$25 or close to US$30, while others are opting for only modest moves or a neutral stance. Read on to see what is driving this split in opinion and how you can track the evolving narrative around the stock. Analyst Price Targets don't always...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 17, 2026

Science Applications Q4 Earnings Beat Estimates, Revenues Miss

SAIC beats on Q4 EPS but misses revenues as sales fall 5%, hit by civilian weakness. The company rolls out its fiscal 2027 outlook.

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
Mar 17, 2026

Semtech's Q4 Earnings Surpass Estimates, Revenues Increase Y/Y

SMTC tops Q4 estimates as revenues rise 9% on strong data center demand, though margins decline amid higher expenses.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
StockStory
Mar 16, 2026

3 Russell 2000 Stocks We Steer Clear Of

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the resilience and financial flexibility of large-cap firms, making careful selection crucial.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 16, 2026

Is Amkor Stock Undervalued Amid Rising AI Packaging & HPC Demand?

AMKR rides AI and HPC demand while trading at a steep valuation discount, even as heavy 2026 capex, seasonal Q1 softness and a secondary share sale shape outlook.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.